<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04816864</url>
  </required_header>
  <id_info>
    <org_study_id>4thMilitaryH</org_study_id>
    <nct_id>NCT04816864</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of His Bundle Pacing Validated by Extracardiac Vagal Nerve Stimulation</brief_title>
  <acronym>HIS-STORY</acronym>
  <official_title>Safety and Efficacy of HIs Bundle Pacing Validated by electrophySiological STudy, autonOmic Tests and extRacardiac Vagal Nerve Stimulation (HIS-STORY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>4th Military Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Subcarpathian Center for Cardiovascular Intervention</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mazovian Speciality Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wroclaw Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>4th Military Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different studies for extracardiac vagal nerve stimulation (ECANS) have been published and&#xD;
      confirmed the influence of the vagus nerve on automaticity and conduction properties of the&#xD;
      sinus node, atria, atrioventricular node, as well as the His-Purkinje system (HPS) and&#xD;
      ventricles. However, there are limited data on the clinical value and impact of ECANS as well&#xD;
      as vagus nerve activity on the parameters of permanent His-bundle (HB) or left bundle branch&#xD;
      (LBB) pacing. Moreover, there have been no prospective studies evaluating the feasibility and&#xD;
      efficacy of ECANS and the management of ECANS-induced scenarios, such as an exit block,&#xD;
      increase in pacing threshold, as well as vagally mediated arrhythmias and conduction&#xD;
      abnormalities in patients with physiological conduction system pacing (HB/LBB pacing).&#xD;
&#xD;
      The objective of the HIS-STORY study in humans is to evaluate the clinical value of ECANS in&#xD;
      patients with HB/LBB pacing for further development of patient-centered management strategy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, prospective, open-label, randomized, interventional study enrolling&#xD;
      patients with indications for permanent cardiac pacing according to the current European&#xD;
      Society of Cardiology Guidelines on Cardiac Pacing. All participants will undergo permanent&#xD;
      pacemaker implantation for HB or LBB pacing. Subsequently, an invasive electrophysiological&#xD;
      study (EPS) and ECANS will be performed. The 2 x 2 randomisation will be performed, i.e.&#xD;
      right vs left side superior ECANS and blinded for operator ultrasonography guided effective&#xD;
      vs ineffective inferior vagal nerve stimulation). The randomisation will prove the&#xD;
      feasibility and efficacy of superior ECANS and feasibility, efficacy, and reproducibility of&#xD;
      ultrasonography guided inferior ECANS. All the measured parameters as well as demographic and&#xD;
      clinical data will be recorded in the study database. Patients with an exit block or an&#xD;
      increase in a pacing threshold of an HB/LBB electrode will be further managed by&#xD;
      electrophysiologists from the research group. The management will be based on clinical&#xD;
      assessment and patient's decision and may involve pacemaker reprogramming, pacemaker upgrade&#xD;
      with a back-up pacing electrode implantation, or cardio-neuro-ablation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Loss of HB/LBB capture or significant increase in pacing threshold</measure>
    <time_frame>0-12 months after HB/LBB pacemaker implantation</time_frame>
    <description>significant increase in pacing threshold = above the permanently programmed impulse amplitude of HB/LBB electrode induced by ECANS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A nonsignificant increase in pacing threshold</measure>
    <time_frame>0-12 months after HB/LBB pacemaker implantation</time_frame>
    <description>below the permanently programmed impulse amplitude of HB/LBB electrode induced by ECANS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolongation of the stimulus-QRS interval during HB/LBB pacing induced by ECANS</measure>
    <time_frame>0-12 months after HB/LBB pacemaker implantation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Any arrhythmia induced by ECANS</measure>
    <time_frame>0-12 months after HB/LBB pacemaker implantation</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Permanent His Bundle Pacing</condition>
  <condition>Permanent Left Bundle Branch Pacing</condition>
  <arm_group>
    <arm_group_label>ECANS started from the right vagus nerve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>superior ECANS and ultrasonography guided inferior ECANS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ECANS started from the left vagus nerve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>superior ECANS and ultrasonography guided inferior ECANS</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>extracardiac vagal nerve stimulation (ECANS) + EPS</intervention_name>
    <description>The study intervention will consist of 3 steps, all of which will be performed under general anesthesia:&#xD;
EPS with the measurement of parameters of atrioventricular conduction and programmed atrial and ventricular pacing.&#xD;
ECANS of the right and the left vagus nerve (from the right and left internal jugular vein, respectively; patients will be randomized to start from the right or the left side) performed during: 1) the patient's spontaneous heart rhythm (if present); 2) HB/LBB pacing with permanently programmed impulse parameters; 3) HB/LBB pacing at a pacing threshold of +0.1 V; and 4) 5 minutes after intravenous injection of atropine (0.02-0.04 mg/kg).&#xD;
EPS with the measurement of parameters of atrioventricular conduction and programmed atrial and ventricular pacing.</description>
    <arm_group_label>ECANS started from the left vagus nerve</arm_group_label>
    <arm_group_label>ECANS started from the right vagus nerve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  signed informed consent form&#xD;
&#xD;
          -  effective and stable HB or LBB pacing&#xD;
&#xD;
          -  sinus rhythm during the intervention procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindications to invasive EPS&#xD;
&#xD;
          -  contraindications to general anesthesia&#xD;
&#xD;
          -  contraindications to atropine administration (e.g., glaucoma)&#xD;
&#xD;
          -  persistent atrial fibrillation or atrial flutter&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  diseases that may cause autonomic system neuropathy&#xD;
&#xD;
          -  use of medications that may affect the parasympathetic system&#xD;
&#xD;
          -  a history of cardiac surgery&#xD;
&#xD;
          -  a history of ablation due to arrhythmia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krystian Josiak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>4th Military Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Krystian Josiak, MD, PhD</last_name>
    <phone>+48 516625985</phone>
    <email>kjosiak@4wsk.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>4th Military Hospital, Cardiology Department</name>
      <address>
        <city>Wroclaw</city>
        <state>Dolnoslaskie</state>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krystian Josiak, MD, PhD</last_name>
      <phone>+48 261660223</phone>
      <email>kjosiak@4wsk.pl</email>
    </contact>
    <investigator>
      <last_name>Dorota Zyśko, prof, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dariusz Jagielski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paweł Szymkiewicz, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotrowska Katarzyna, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bartosz Biel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Przemysław Skoczyński, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joanna Relewicz, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mazovian Speciality Hospital, Cardiology Department</name>
      <address>
        <city>Radom</city>
        <state>Mazowieckie</state>
        <zip>26-617</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarosław Kosior, MD, PhD</last_name>
      <phone>+48 3613676</phone>
      <email>jaroslaw.kosior@icloud.com</email>
    </contact>
    <investigator>
      <last_name>Jarosław Kosior, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janusz Śledź, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Subcarpathian Center for Cardiovascular Intervention</name>
      <address>
        <city>Sanok</city>
        <state>Podkarpackie</state>
        <zip>38-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastion Stec, prof, MD</last_name>
      <phone>+48 600298022</phone>
      <email>smstec@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Sebastian Stec, prof, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoni Wilczek, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Abdelrahman M, Subzposh FA, Beer D, Durr B, Naperkowski A, Sun H, Oren JW, Dandamudi G, Vijayaraman P. Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. J Am Coll Cardiol. 2018 May 22;71(20):2319-2330. doi: 10.1016/j.jacc.2018.02.048. Epub 2018 Mar 10.</citation>
    <PMID>29535066</PMID>
  </results_reference>
  <results_reference>
    <citation>Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014 Aug;16(8):1189-96. doi: 10.1093/europace/euu011. Epub 2014 Feb 7.</citation>
    <PMID>24509688</PMID>
  </results_reference>
  <results_reference>
    <citation>Dandamudi G, Vijayaraman P. How to perform permanent His bundle pacing in routine clinical practice. Heart Rhythm. 2016 Jun;13(6):1362-6. doi: 10.1016/j.hrthm.2016.03.040. Epub 2016 Mar 22. Review.</citation>
    <PMID>27016475</PMID>
  </results_reference>
  <results_reference>
    <citation>Josiak K, Nowak K, Fuglewicz A, Jagielski D, Banasiak W, Ponikowski P. Does right ventricular pacing increase the risk of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator? Kardiol Pol. 2014;72(4):381-4. doi: 10.5603/KP.2014.0073. Review.</citation>
    <PMID>24733700</PMID>
  </results_reference>
  <results_reference>
    <citation>Sharma PS, Dandamudi G, Naperkowski A, Oren JW, Storm RH, Ellenbogen KA, Vijayaraman P. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 2015 Feb;12(2):305-12. doi: 10.1016/j.hrthm.2014.10.021. Epub 2014 Oct 22.</citation>
    <PMID>25446158</PMID>
  </results_reference>
  <results_reference>
    <citation>Burri H, Jastrzebski M, Vijayaraman P. Electrocardiographic Analysis for His Bundle Pacing at Implantation and Follow-Up. JACC Clin Electrophysiol. 2020 Jul;6(7):883-900. doi: 10.1016/j.jacep.2020.03.005. Review.</citation>
    <PMID>32703577</PMID>
  </results_reference>
  <results_reference>
    <citation>Zyśko D, Gajek J, Koźluk E, Mazurek W. Electrocardiographic characteristics of atrioventricular block induced by tilt testing. Europace. 2009 Feb;11(2):225-30. doi: 10.1093/europace/eun299. Epub 2008 Nov 5.</citation>
    <PMID>18987129</PMID>
  </results_reference>
  <results_reference>
    <citation>Klank-Szafran M, Stec S, Sledź J, Janion M. [Radiofrequency ablation and cardioneuroablation for AVNRT and atrioventricular block]. Kardiol Pol. 2010 Jun;68(6):720-4. Polish.</citation>
    <PMID>20806214</PMID>
  </results_reference>
  <results_reference>
    <citation>Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. &quot;Cardioneuroablation&quot;--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005 Jan;7(1):1-13.</citation>
    <PMID>15670960</PMID>
  </results_reference>
  <results_reference>
    <citation>Stec S, Dobaj Ł, Śledź A, Stępień-Wałek AM, Ton V, Śledź J. Cardioneuroablation for management of cardioinhibitory vasovagal syncope and pacemaker complications. HeartRhythm Case Rep. 2020 May 11;6(8):531-534. doi: 10.1016/j.hrcr.2020.04.021. eCollection 2020 Aug.</citation>
    <PMID>32817835</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 21, 2021</study_first_submitted>
  <study_first_submitted_qc>March 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2021</study_first_posted>
  <last_update_submitted>March 24, 2021</last_update_submitted>
  <last_update_submitted_qc>March 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>4th Military Hospital</investigator_affiliation>
    <investigator_full_name>Krystian Josiak</investigator_full_name>
    <investigator_title>Krystian Josiak, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>His bundle pacing</keyword>
  <keyword>left bundle branch pacing</keyword>
  <keyword>extracardiac vagal nerve stimulation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

